Comment on: “Enzalutamide: A Step Towards Pharmacokinetic-Based Dosing in Men with Metastatic Castration-Resistant Prostate Cancer”
Crossref DOI link: https://doi.org/10.1007/s40262-015-0350-7
Published Online: 2015-12-09
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gibbons, Jacqueline A.
Funding for this research was provided by:
Medivation
Astellas Pharma Global Development
License valid from 2015-12-09